Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Cloherty

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Biomedicines|February 25, 2022
Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological PatientsCarlotta Cerva, Romina Salpini, Mohammad Alkhatib, et al.
Bulletin of the World Health Organization|June 13, 2025
Children with hepatitis B virus infections, Democratic Republic of the CongoCamille E Morgan, Kimberley A Powers, Jess K Edwards, et al.
Microorganisms|November 21, 2020
Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV MarkersRomina Salpini, Vincenzo Malagnino, Lorenzo Piermatteo, et al.
The Journal of Infectious Diseases|April 30, 2025
Residual risk of hepatitis B virus (HBV) mother-to-child transmission and gaps in HBV care cascades among pregnant women in The Gambia: the INFANT-B studyGibril Ndow, Rohey Bangura, Erwan Vo-Quang, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2025
Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy studyJeanne Perpétue Vincent, Olivier Ségéral, Dramane Kania, et al.
Journal of Hepatology|July 23, 2022
Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHBMan-Fung Yuen, Stephen Locarnini, Tien Huey Lim, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2022
The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness effortsFrancisco Averhoff, Michael Berg, Mary Rodgers, et al.
Research Square|October 27, 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Seropositivity in South-Central Uganda, During 2019 - 2021Charles Ssuuna, Ronald Moses Galiwango, Edward Nelson Kankaka, et al.
Antiviral Research|April 19, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferonDaniel Q Huang, Liang Shen, Wah Wah Phyo, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Biomedicines|February 25, 2022
Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological PatientsCarlotta Cerva, Romina Salpini, Mohammad Alkhatib, et al.
Bulletin of the World Health Organization|June 13, 2025
Children with hepatitis B virus infections, Democratic Republic of the CongoCamille E Morgan, Kimberley A Powers, Jess K Edwards, et al.
Microorganisms|November 21, 2020
Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV MarkersRomina Salpini, Vincenzo Malagnino, Lorenzo Piermatteo, et al.
The Journal of Infectious Diseases|April 30, 2025
Residual risk of hepatitis B virus (HBV) mother-to-child transmission and gaps in HBV care cascades among pregnant women in The Gambia: the INFANT-B studyGibril Ndow, Rohey Bangura, Erwan Vo-Quang, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2025
Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy studyJeanne Perpétue Vincent, Olivier Ségéral, Dramane Kania, et al.
Journal of Hepatology|July 23, 2022
Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHBMan-Fung Yuen, Stephen Locarnini, Tien Huey Lim, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2022
The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness effortsFrancisco Averhoff, Michael Berg, Mary Rodgers, et al.
Research Square|October 27, 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Seropositivity in South-Central Uganda, During 2019 - 2021Charles Ssuuna, Ronald Moses Galiwango, Edward Nelson Kankaka, et al.
Antiviral Research|April 19, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferonDaniel Q Huang, Liang Shen, Wah Wah Phyo, et al.
Pageof 13